cellebrite di ltd - CLBT

CLBT

Close Chg Chg %
18.76 0.24 1.28%

Pre-Market

19.00

+0.24 (1.28%)

Volume: 2.05M

Last Updated:

Nov 20, 2024, 4:00 PM EDT

Company Overview: cellebrite di ltd - CLBT

CLBT Key Data

Open

$18.73

Day Range

18.72 - 19.26

52 Week Range

7.91 - 21.00

Market Cap

$3.90B

Shares Outstanding

208.08M

Public Float

86.02M

Beta

1.50

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.55

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.47M

 

CLBT Performance

1 Week
 
5.99%
 
1 Month
 
3.36%
 
3 Months
 
9.39%
 
1 Year
 
121.49%
 
5 Years
 
N/A
 

CLBT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 8
Full Ratings ➔

About cellebrite di ltd - CLBT

Cellebrite DI Ltd. engages in the provision of digital investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Its services include training and advisory, value realization, advanced services, and technical customer support. The firm also offers software solutions and analytic tools designed to accelerate digital investigations and address the growing complexity of handling crime and security challenges in the digital era. The company was founded on April 13, 1999 and is headquartered in Petach Tikva, Israel.

CLBT At a Glance

Cellebrite DI Ltd.
94 Shlomo Shmelzer Road
Petach Tikva, HaMerkaz 4970602
Phone 972-73-394-8000 Revenue 325.11M
Industry Packaged Software Net Income -81,100,000.00
Sector Technology Services 2023 Sales Growth 20.121%
Fiscal Year-end 12 / 2024 Employees 1,008
View SEC Filings

CLBT Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 5.065
Price to Book Ratio 51.444
Price to Cash Flow Ratio 16.135
Enterprise Value to EBITDA 31.366
Enterprise Value to Sales 4.177
Total Debt to Enterprise Value 0.01

CLBT Efficiency

Revenue/Employee 322,529.762
Income Per Employee -80,456.349
Receivables Turnover 4.208
Total Asset Turnover 0.685

CLBT Liquidity

Current Ratio 1.641
Quick Ratio 1.60
Cash Ratio 1.193

CLBT Profitability

Gross Margin 83.627
Operating Margin 10.237
Pretax Margin -23.242
Net Margin -24.945
Return on Assets -17.088
Return on Equity -150.078
Return on Total Capital -167.766
Return on Invested Capital -127.129

CLBT Capital Structure

Total Debt to Total Equity 41.298
Total Debt to Total Capital 29.228
Total Debt to Total Assets 2.615
Long-Term Debt to Equity 26.765
Long-Term Debt to Total Capital 18.943
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cellebrite Di Ltd - CLBT

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
- 246.25M 270.65M 325.11M
Sales Growth
- - +9.91% +20.12%
-
Cost of Goods Sold (COGS) incl D&A
- 42.56M 50.75M 53.23M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- 7.01M 9.19M 10.01M
Depreciation
- 5.04M 6.37M 6.66M
Amortization of Intangibles
- 1.97M 2.83M 3.35M
COGS Growth
- - +19.24% +4.90%
-
Gross Income
- 203.69M 219.91M 271.88M
Gross Income Growth
- - +7.96% +23.63%
-
Gross Profit Margin
- +82.72% +81.25% +83.63%
2020 2021 2022 2023 5-year trend
SG&A Expense
145.87K 189.87M 216.90M 238.60M
Research & Development
- 65.54M 80.62M 84.39M
Other SG&A
145.87K 124.33M 136.28M 154.21M
SGA Growth
- +130,066.25% +14.24% +10.00%
Other Operating Expense
- - - 90.41K
-
Unusual Expense
14.99M (67.87M) (114.90M) 119.39M
EBIT after Unusual Expense
(15.23M) 81.69M 117.91M (86.11M)
Non Operating Income/Expense
53.90K 1.17M 4.08M 11.30M
Non-Operating Interest Income
- 1.12M 2.34M 10.72M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 564.00K 1.23M 753.00K
Interest Expense Growth
- - +117.55% -38.63%
-
Gross Interest Expense
- 564.00K 1.23M 753.00K
Interest Capitalized
- - - -
-
Pretax Income
(15.18M) 82.31M 120.76M (75.56M)
Pretax Income Growth
- +642.34% +46.72% -162.57%
Pretax Margin
- +33.42% +44.62% -23.24%
Income Tax
- 10.91M (45.00K) 5.54M
Income Tax - Current - Domestic
(7.67K) 9.66M (2.57M) 3.01M
Income Tax - Current - Foreign
- 2.88M 4.92M (2.88M)
Income Tax - Deferred - Domestic
(30.63K) (10.00K) (85.00K) 1.60M
Income Tax - Deferred - Foreign
- (1.63M) (2.31M) 3.81M
Income Tax Credits
- - - (38.30K)
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (4.69M)
-
Consolidated Net Income
(15.18M) 71.40M 116.11M (81.10M)
Minority Interest Expense
- - - -
-
Net Income
(15.18M) 71.40M 116.11M (81.10M)
Net Income Growth
- +570.46% +62.63% -169.85%
Net Margin Growth
- +28.99% +42.90% -24.95%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(15.18M) 71.40M 116.11M (81.10M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(15.18M) 71.40M 116.11M (81.10M)
EPS (Basic)
-0.2023 0.4958 0.6355 -0.4265
EPS (Basic) Growth
- +345.08% +28.18% -167.11%
Basic Shares Outstanding
75.00M 144.00M 182.69M 190.15M
EPS (Diluted)
-0.2023 0.442 0.5942 -0.4265
EPS (Diluted) Growth
- +318.49% +34.43% -171.78%
Diluted Shares Outstanding
75.00M 161.54M 195.39M 190.15M
EBITDA
(236.28K) 20.83M 12.20M 43.29M
EBITDA Growth
- +8,915.39% -41.44% +254.92%
EBITDA Margin
- +8.46% +4.51% +13.32%

Snapshot

Average Recommendation BUY Average Target Price 19.857
Number of Ratings 8 Current Quarters Estimate 0.061
FY Report Date 12 / 2024 Current Year's Estimate -1.193
Last Quarter’s Earnings -0.99 Median PE on CY Estimate N/A
Year Ago Earnings -0.43 Next Fiscal Year Estimate 0.259
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 5 7 6
Mean Estimate 0.06 0.04 -1.19 0.26
High Estimates 0.08 0.05 -0.13 0.33
Low Estimate 0.04 0.03 -1.44 0.20
Coefficient of Variance 24.00 20.51 -39.66 17.57

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 8
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Cellebrite Di Ltd in the News